AwardedCzechiaGoodsCZK 9,900,000
Edotreotid [2026]
- Published
- Published 21 July 2026
Overview
Masarykův onkologický ústav procured supplies of the medicinal product Edotreotid (ATC group V09IX09) according to specifications outlined in the tender documentation. The contract was awarded to Novartis s.r.o. on 10 July 2026 for 9,890,884 CZK.
Key details
- Country
- Czechia
- Status
- Awarded
- Category
- Goods
- Estimated value
- CZK 9,900,000
- Procedure
- Direct
- Published
- 21 July 2026
Pharmaceutical products
Award outcome
- Awarded value
- CZK 9,890,884
- Award date
- 10 July 2026
- Contract period
- — → 9 July 2029
- Novartis s.r.o.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
21 July 2026
Contracting authority
Masarykův onkologický ústav
Procuring entityBrno, Czechia
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.